The benefits of continuous manufacturing a clear: increased output at lower cost with less waste. At least on paper, but 24/7 production can be a challenge for traditional drug firms says the team ...
Biopharma 4.0 is often presented as an all-or-nothing proposition, when in fact its components have all been around for a while and have independent value. It appears the major challenge will be ...
Researchers at the Department of Chemical Engineering, Indian Institute of Technology, India, have investigated the effects of oxidative stress on the production of monoclonal antibodies (mAbs), and ...
Prof. Rathore is the first researcher in India to receive this award; he has been recognized for his contributions to biopharmaceutical research The 2020 award includes a grant to support research ...
Impurity control is a fundamental step in biologics manufacturing, crucial for safeguarding the safety, efficacy and consistency of therapeutic products. A critical component of this process is the ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) has honored Prof. Anurag Rathore, a scientist at the Indian Institute of Technology (IIT) Delhi, with an Agilent Thought ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results